IP Library › Granted Patent US 11,779,549
Granted Patent B2
US 11,779,549 · App. 17/895,008 · Granted Oct 10, 2023

Treatment of Fragile X Syndrome with cannabidiol

Inventors: Marcel Bonn-Miller (Lexington, NC); Nancy Tich (Saint Paul, MN); Donna Gutterman (Raleigh, NC); John Messenheimer (Moncure, NC); Terri Sebree (Gladwyne, PA)
Assignee: ZYNERBA PHARMACEUTICALS, INC.
A61K31/05A61K9/0014A61K9/06A61K36/185A61P25/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,779,549
App. No.
17/895,008
Granted
Oct 10, 2023
Kind
B2
Abstract

The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.

Claims (2)

1. A method of reducing manic/hyperactive behavior associated with a human suffering from Fragile X Syndrome comprising administering a therapeutically effective amount of isolated cannabidiol to the human suffering from Fragile X Syndrome to effectively treat the Fragile X Syndrome in the human in need thereof.

2. A method of reducing compulsive behavior associated with a human suffering from Fragile X Syndrome comprising administering a therapeutically effective amount of isolated cannabidiol to the human suffering from Fragile X Syndrome to effectively treat the Fragile X Syndrome in the human in need thereof.

Assignments (2)
SUPPLEMENTAL CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded May 18, 2026
From: HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.)
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075642/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2023
From: BONN-MILLER, MARCEL; TICH, NANCY; GUTTERMAN, DONNA; MESSENHEIMER, JOHN; SEBREE, TERRI
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 064712/0149 →